Drug Screening Market Analysis
Drug Screening Market, Dynamics, and Market Analysis- 2022-2028 See less
Drug Screening Market, Dynamics, and Market Analysis- 2022-2028
The report on the Drug Screening Market is segmented by Product & Services (Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Services), By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other), By End User (Workplace, Criminal Justice Systems, and Law Enforcement Agencies, Drug Treatment Centers, Pain Management Centers, Drug Testing Laboratories, Others), and Region. It also covers the COVID-19 Impact Analysis and Forecast to 2026. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Drug Screening market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2028.
The report on the Drug Screening Market is segmented by Product & Services (Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Services), By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other), By End User ...
The drug screening market is estimated to grow from USD 5.24 billion in 2021 to USD 15.52 billion by 2028 at a healthy CAGR of 16.74% during the forecast period.
Wish to get a free sample? Click here.
What is drug screening?
Drug screening is defined as the process of collecting and analyzing blood, hair, urine, or saliva to detect the presence of contaminants and chemicals left in the body as a result of drug consumption. In this process, potential drugs are identified and optimized before selecting a candidate drug for a clinical trial. Drug screening is done in order to determine if a person is or has consumed drugs at a certain point in time.
COVID-19 Impact on Drug Screening Market
The covid-19 outbreak affected the growth of the drug screening market for a short period of time due to disruption in business and economic activities across geographies. Postponement of non-essential medical services amid the covid-19 outbreak also affected the growth of the drug screening market. However, with the reopening of the economy, the market is likely to experience growth during the review period.
Increasing drug and alcohol testing measures in various countries to curb the menace of drug and alcohol abuse is likely to drive market growth significantly.
Want to have a closer look at this report, Download a free sample
Key players operating in the drug screening market are-
The workplace segment accounted for the largest market share in 2021.
Based on end users, the market has been divided into workplace, criminal justice systems and law enforcement agencies, drug treatment centers, pain management centers, drug testing laboratories, and others. The segment growth can be attributed to a rising safety concern for the staff.
The market in North America accounted for the largest share in 2021 due to the high consumption of drugs and alcohol. Additionally, supporting government measures to curb the use of drugs is likely to add significantly to the market growth. The market in Europe accounted for the second-largest market share in 2021.
Want to know which region offers the best growth opportunities then, Click Here.
Critical Questions answered in this report-
Here is the list of the group of customers that the Drug Screening Market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to firstname.lastname@example.org.
The drug screening market size is expected to reach USD 15.52 billion in the foreseeable future.
Alere Inc. (The U.S), Laboratory Corporation of America Holdings (The U.S), OraSure Technologies (The U.S), Quest Diagnostics (The U.S), Thermo Fisher Scientific (The U.S), Alfa Scientific Designs, Inc. (The U.S), MPD Inc. (The U.S), Lifeloc Technologies, Inc. (The U.S), Omega Laboratories Inc. (The U.S), Sciteck Diagnostics Inc (The U.S), ACM GLOBAL LABORATORIES (The U.S), and Carehealth America Corporation (The U.S) are among the key players in the market.
The market is expected to grow at an impressive CAGR of 16.74% in the coming years.
North America accounted for the largest share of the market in 2021.
The workplace segment accounted for the largest share of the market in 2021.
Increasing drug and alcohol testing measures in various countries to curb the menace of drug and alcohol abuse, an increase in consumption of drugs and alcohol across the geographies, particularly among the youth and elder population are the factors driving the growth of the market.
Drug screening distributors, Drug screening suppliers, Drug screening manufacturers, Logistics organizations, and Government Bodies are the target audience in the market.